[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:alpha-mannosidosis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":33,"states":34},"Alpha-Mannosidosis",4,[7,15,21,27],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT02254863","UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells",[11],"Phase 1","RECRUITING","2026-08-26T02:17:07.954622Z","2026-05-05T02:43:26.720663Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06184503","Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3",[],"2026-08-26T02:19:18.331180Z","2026-05-13T02:55:06.422256Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT04528355","Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC",[],"2026-08-26T02:16:24.970704Z","2026-05-13T02:55:06.255132Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT03333200","Longitudinal Study of Neurodegenerative Disorders",[],"2026-08-26T02:18:51.009190Z","2026-05-13T02:55:06.121889Z",[],[]]